Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,041,972 shares of the medical equipment provider's stock after selling 73,052 shares during the period. Wellington Management Group LLP owned about 0.85% of Intuitive Surgical worth $1,587,788,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical during the 4th quarter worth about $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $82,517,000. Sycomore Asset Management boosted its stake in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $43.03 during trading hours on Friday, reaching $451.58. The company had a trading volume of 4,106,917 shares, compared to its average volume of 1,542,631. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business's 50 day moving average price is $545.18 and its 200-day moving average price is $532.30. The firm has a market cap of $160.84 billion, a PE ratio of 70.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Insider Activity

In other news, EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company's stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company's stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on ISRG shares. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, December 5th. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Evercore ISI boosted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.